Gregory Fosheim, Esq.
Gregory (Greg) E. Fosheim provides counsel on a wide array of corporate, transactional and regulatory compliance matters across the healthcare and life sciences industry. Drawing on his extensive laboratory and public health background, he regularly advises on clinical and diagnostic laboratory matters, anatomic pathology and fertility laboratory compliance. Greg represents hospitals, health systems and physician practice management companies in all aspects of transactional and operational matters, particularly those with regulatory, licensing, accreditation and policy considerations. He has also negotiated several acquisitions and sales of proton therapy centers.
During his time as a microbiologist at the Centers for Disease Control and Prevention’s Division of Healthcare Quality Promotion, Greg routinely advised and trained hospital and public health laboratories in various techniques and best practices, including infection control, quality assurance, quality management systems and compliance with the Clinical Laboratory Improvement Amendments. He also addressed many national and international hospital outbreaks. Now, clients turn to him for legal counsel on outbreak response and emergency preparedness, clinical laboratory operations and innovative care delivery modalities.
Greg also writes, speaks and advises on quality, access and patient empowerment in the provision of equitable healthcare services, with a particular focus on helping covered entities comply with the nondiscrimination provisions of Section 1557 of the Affordable Care Act and Section 504 of the Rehabilitation Act of 1973.